« Back
Home /
PRH1 antibody

PRH1 antibody

Item no.	FNab06772-100ug
Manufacturer	FineTest
Amount	100 ug
Category	Antibodies Primary Antibodies
Type	Antibody Monoclonal
Format	Liquid
Applications	WB, IF, ELISA
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Purity	≥95% as determined by SDS-PAGE
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	Salivary acidic proline-rich phosphoprotein 1/2,Db-s,PRP-1/PRP-2,Parotid acidic protein (Pa),Parotid double-band protein,Parotid isoelectric focusing variant protein (PIF-S),Parotid proline-rich protein 1/2,Pr1/Pr2,Protein C,Salivary acidic proline-rich phosphoprotein 1/2,Salivary acidic proline-rich phosphoprotein 3/4 Alternative names: Db-F,PIF-F,PRP-3/PRP-4,Protein A,Peptide P-C,PRH1,PRPC
Available
Manufacturer - Targets	PRH1
Storage Conditions	PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months(Avoid repeated freeze / thaw cycles.)
Clonality	polyclonal
Immunogen	proline-rich protein HaeIII subfamily 1
Observed MW	17 kDa
Purification	Immunogen affinity purified
Recommended dilution	WB: 1:200-1:1000; IF: 1:20-1:200
Manufacturer - Research Area	Signal Transduction, Developmental biology
Manufacturer - Synonym	Salivary acidic proline-rich phosphoprotein 1/2, Db-s, PRP-1/PRP-2, Parotid acidic protein (Pa), Parotid double-band protein, Parotid isoelectric focusing variant protein (PIF-S), Parotid proline-rich protein 1/2, Pr1/Pr2, Protein C, Salivary acidic proline-rich phosphoprotein 1/2, Salivary acidic proline-rich phosphoprotein 3/4 Alternative names: Db-F, PIF-F, PRP-3/PRP-4, Protein A, Peptide P-C, PRH1, PRPC

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.